BJU internationalHumansMaleDocetaxelNitrilesBenzamides
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.
Yu Yang Soon, Ian C Marschner, I Manjula Schou, Christopher J Sweeney, Ian D Davis, Martin R Stockler, Andrew J Martin
Published: 202610.1111/bju.70065
Abstract
OBJECTIVE: To apply a trial emulation method using the 'ENZAlutamide in first line androgen deprivation therapy for METastatic prostate cancer' (ENZAMET) trial data to assess the effects of adding early docetaxel to enzalutamide on overall survival (…
Preview only. Read the full abstract at the source